NewsUp one level
A new job offer is available in the "Job Section"
Cristal Therapeutics starts clinical phase I trial with nanomedicine CriPec® docetaxel in patients with solid tumours
Maastricht, The Netherlands, September 29, 2015 – Cristal Therapeutics, a privately-held life sciences company developing innovative drugs against cancer and other diseases, today announced the recent start of a clinical phase I trial with its lead candidate CriPec® docetaxel in patients with solid tumours. For this trial, patients are being recruited in two clinical centres in The Netherlands and in Belgium. The first trial data will be available in the course of Q2 2016.
The European Commission made public the final drafts documents to provide potential participants with the currently expected main lines of the work programmes 2016-2017. However, they are draft documents not yet finally endorsed by the Commission and their contents does not in any way prejudge the final decision of the Commission.
A US-Ireland partnership involving researchers at Queen’s University has been awarded £2.9m to develop new treatments for pancreatic cancer, which is the fifth most common cause of cancer deaths in the UK.
Find the right information and partners for the H2020 2016 Calls related to Nanomedicine
The Award winners will be presented at the BIO-Europe conference in Munich in November 2015.
The EU-funded consortium ENATRANS (Enabling Nanomedicine TRANSlation) launches the first Translation Advisory Board (TAB), a new instrument to provide free of charge advice and supports to ambitious international nanobiomedicine projects.
The call for suggestions for the European CTO of the Year 2015 is now open - who is the most inspiring, innovative and foresighted technology leader you know in Europe?
Last elections of the ETPN Executive Board (ExBo) took place in 2013, therefore new elections will be organised this year during the General Assembly of the ETPN, on 12th October 2015 in Dublin.
The ETPN released its Newsletter 2/2015, compiling internal news but also nanomedicine news, upcoming events, information on future calls...
The Project Combines Expertise of 9 Partners in 8 Countries to Foster Nanomedicine Innovation and Facilitate Regulatory Approval.
The EuroNanoMed ERA-NET released a short clip on Regenerative Nanomedicine to promote the use of Nanoparticles for the regeneration of bone fractures and osteoporosis.
From the 22nd to the 23thd of June, the JRC hosted the first meeting of the national platforms on nanomedicine with 13 established European platforms.
The FP7 nanomedicine project NAMDIATREAM has been awarded best project during the EuroNanoForum which took place from June 10th to 12th in Riga.
The Greek Nanomedicine Platform has been established to promote Nanomedicine Research and its Translation into Clinical Practice in Greece under the umbrella of Nano|Net.
The European Technology Platform for Nanomedicine (ETPN) and the EU funded ENATRANS Initiative (Enabling NAnomedicine TRANSlation), are happy to announce their Nanomedicine panel in Philadelphia at the BIO Convention 2015, in the “Next generation biotherapeutics – the future is now” track.
An Uppsala Antibiotics Centre is to be created at Uppsala University. This was announced by Deputy Vice-Chancellor Anders Malmberg at the opening of the Uppsala Health Summit conference. The goal is for this interdisciplinary centre to be a regional, national and international knowledge resource and forum in the area of antibiotic resistance.
The 4th call for proposals of the mobility programme TECNIOspring (Marie Curie Actions) is already open.
The European Technology Platform for Nanomedicine is co-organising the ETP Nanomedicine Brokerage and Universities "Small Speeches" Session during CLINAM 2015. This session is dedicated to research institutes, academia, large and small companies to present their activities and potential project ideas for collaborative research during short talks.
Crossing Biological Barriers – Advances in Nanocarrier Design for Targeted Drug Delivery, will take place on 9-11 November 2015 in the city of Dresden. The Call for Papers is open now!
Prof. Mike Eaton, Vice Chair of the Nanotherapeutics Working Group of the European Technology Platform on Nanomedicine has elaborated a guide for developing nanomedicines published in the journal Nanomedicine: Nanotechnology, Biology and Medicine.
The ETPN continues its collaboration with the International Innovation magazine and its Nanomedicine series of articles. Dr Arantxa Sanz from the Institute of Bioengineering of Catalonia, Executive Manager of NanoMed Spain and member of the ETPN, highlights the promising development of nano-based solutions to fight infectious diseases.
Enabling nanomedicine solutions for healthcare by supporting translation from lab to bedside
Compete, innovate and win €1 million
The BioBusiness WEEK training session is part of the Erasmus Mundus program, NANOFAR. Yet PhD students external to that program are welcome to attend the workshop and explore the field of innovative entrepreneurship. It will take place in Angers (France) from 8th to 12th of June